530 likes | 691 Views
Caveats. Does not consider many newer drugsDPP-IVDetemirExenatide only briefly touched onDoesn't include data from the latest type 2 studiesUKPDS 80 and 81ADVANCE, ACCORD. Patient education. Should be offered to all at diagnosisIdeally structured group education in accordance with DoH guidanc
E N D